CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $46.37, but opened at $49.21. CochLear shares last traded at $49.21, with a volume of 241 shares trading hands.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Royal Bank Of Canada downgraded shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price on the stock. in a research report on Thursday, July 16th. Zacks Research upgraded shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, UBS Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $117.00.
Get Our Latest Research Report on CochLear
CochLear Stock Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
- Fabrinet’s Sell-Off May Prove It Is One of AI’s Most Misunderstood Stocks
- Orbiting Wealth: Institutions Load Up SpaceX
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
